snyderman nancy lynn MD
SEC Form 4 insider trading activity
snyderman nancy lynn MD has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 3, 2026.
On the most recent filing, snyderman nancy lynn MD is listed as Director at Alkermes plc. Inside the rolling window, snyderman nancy lynn MD reported no open-market purchases and 1 open-market sale totaling $2.2M in ALKS.
Companies traded
Other insiders at ALKS
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has snyderman nancy lynn MD made?
snyderman nancy lynn MD has filed 2 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does snyderman nancy lynn MD trade?
snyderman nancy lynn MD has filed SEC Form 4 disclosures for 1 company, including ALKS.
When was snyderman nancy lynn MD's most recent SEC Form 4 filing?
snyderman nancy lynn MD's most recent SEC Form 4 filing on Tracefour is dated Aug 3, 2026.
What is snyderman nancy lynn MD's total buy and sell value in the current window?
Inside the rolling retention window, snyderman nancy lynn MD bought $0 and sold $2.2M based on SEC Form 4 filings.
What was snyderman nancy lynn MD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 44,472 ALKS shares on 2026-08-03, worth $2.2M, per SEC Form 4 filings.